STRONG STEP
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

STRONG STEP Trademark

Serial Number: 79305466 • Registration: 6998345

STRONG STEP is a trademark filed by Nanjing Liming Bio-Products Co., Ltd on December 7, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Nanjing Liming Bio-Products Co., Ltd (3 trademarks)

116-1 Jiangwangmiao Street,

Entity Type: 99

Trademark Details

Filing Date

December 7, 2020

Registration Date

March 14, 2023

Published for Opposition

December 27, 2022

Goods & Services

Human medicine for preventing, treating and diagnosing gastrointestinal diseases; nutrient preparations for microorganisms to promote the growth, reproduction and identification of microorganisms and complete various physiological activities; medicinal chemical preparations for the treatment of respiratory disease, fertility and pregnancy, sexually transmitted diseases, gastroenteritic diseases; chemical reagents for medical or veterinary use; medical enzyme preparations for medical or veterinary use; medical biologics, namely, medical biological fungicides; medical diagnostic preparations for respiratory disease, fertility and pregnancy, sexually transmitted diseases, gastroenteritic diseases

Medical equipment and instruments for sample collection and processing, namely, diagnostic kits for nucleic acid sample collection, stabilization, transportation and preparation consisting primarily of a specifically designed collection receptacle and also containing a preserving solution and specially designed collection receptacle to collect multiple sample types, including but not limited to saliva, urine, feces, tissue, sputum or blood; medical analysis equipment, namely, stethoscopes for disease prevention, diagnosis, and research; dental equipment, namely, dental picks, dental operating lamps for treating dental diseases; lasers for medical use; X-ray apparatus for medical use; condoms; suture materials

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 21, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 27, 2023 FICS
FINAL DISPOSITION PROCESSED
Jun 27, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 14, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 14, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 14, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 27, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 27, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 7, 2022 NONP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 28, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 10, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 10, 2022 OPNR
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 12, 2022 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 27, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 27, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 27, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 27, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 15, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 14, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 14, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 5, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 5, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 5, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 30, 2021 TROA
REFUSAL PROCESSED BY IB
Jun 20, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 3, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jun 3, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 3, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 2, 2021 CNRT
ASSIGNED TO EXAMINER
May 26, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 9, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 5, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 4, 2021 REPR